Showing results (41-50 of 467) with videos related to
Sort By:
Pageof 47
Drug Discovery Today|June 11, 2009
The path to a successful vaccine adjuvant--'the long and winding road'Derek T O'Hagan, Ennio De GregorioClinical and Vaccine Immunology : CVI|February 22, 2008
Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaquesChien-Hsiung Pan, Nitya Nair, Robert J Adams, et al.Vaccine|August 18, 2004
Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticlesHans-Joachim Mollenkopf, Guido Dietrich, Joachim Fensterle, et al.Pharmaceutics|July 29, 2023
Aluminum Adjuvants-'Back to the Future'Donatello Laera, Harm HogenEsch, Derek T O'HaganMolecular Pharmaceutics|July 15, 2021
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent VaccinesDespo Chatzikleanthous, Derek T O'Hagan, Roberto AdamoCurrent Opinion in Virology|July 10, 2026
The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37Elvira Ianni, Daniela Stranges, Derek T O'HaganEuropean Journal of Immunology|July 11, 2012
The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responsesAndres Mori, Ewa Oleszycka, Fiona A Sharp, et al.Vaccine|November 16, 2004
Cationic microparticles are a potent delivery system for a HCV DNA vaccineDerek T O'Hagan, Manmohan Singh, Christine Dong, et al.Plos One|October 25, 2007
Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigensWalter R Weiss, Anita Kumar, George Jiang, et al.Seminars in Immunology|July 16, 2013
Vaccine adjuvant formulations: a pharmaceutical perspectiveLuis A Brito, Padma Malyala, Derek T O'HaganPageof 47